US 7300650
Reovirus for the treatment of neoplasia
granted A61KA61K35/765A61P
Quick answer
US patent 7300650 (Reovirus for the treatment of neoplasia) held by ONCOLYTICS BIOTECH INC. expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K35/765, A61P, A61P35/00, A61P35/02